Sol-Gel Technologies Competitors and Similar CompaniesClear all
Sol-Gel Technologies's competitors and similar companies include dMed and SciClone Pharmaceuticals.
 Sol-Gel Technologies Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals. |  dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. | |
Founding Date | Founding Date 1997 | Founding Date 2016 | Founding Date 1989 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Ness Ziona, IL HQ | Locations Morrisville, US HQ | Locations Foster City, US HQ |
Employees | Employees 34 | Employees 172 | Employees 1102% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $19.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $160.1m (FY, 2016) |
Net income | Net income ($6.1m) (FY, 2025) | Net income N/A | Net income $30.7m (FY, 2016) |
For sources of this data, please see the company profile
View Company Profiles
dMed
HQ
Morrisville, US
Employees
172
dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company